Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Ma

Showing results (861-870 of 918) with videos related to

Pageof 92
Sort By:
Cancer Research|April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer ProgressionYi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.
Cancer Letters|March 12, 2024
Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancerCanhui Cao, Qian Xu, Zhixian Zhu, et al.
Cancer Letters|February 22, 2025
SRSF12 deficiency enhances tumor innervation and accelerates pancreatic tumorigenesisMin-Wei Yang, Qin-Yuan Jia, Da-Peng Xu, et al.
Molecular Cancer|November 8, 2011
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumorsXi Xia, Teng Ji, Pingbo Chen, et al.
Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Nature Communications|May 2, 2018
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylationDan Liu, Xiao-Xue Zhang, Meng-Chen Li, et al.
Cell Reports|March 2, 2022
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancerTian-Qi Gong, Yi-Zhou Jiang, Chen Shao, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Signal Transduction and Targeted Therapy|September 12, 2022
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivationGuan-Nan Li, Xue-Jiao Zhao, Zhen Wang, et al.
Nature Genetics|September 28, 2023
Molecular classification of hormone receptor-positive HER2-negative breast cancerXi Jin, Yi-Fan Zhou, Ding Ma, et al.
Pageof 92

Showing results (861-870 of 918) with videos related to

Sort By:
Pageof 92
Cancer Research|April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer ProgressionYi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.
Cancer Letters|March 12, 2024
Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancerCanhui Cao, Qian Xu, Zhixian Zhu, et al.
Cancer Letters|February 22, 2025
SRSF12 deficiency enhances tumor innervation and accelerates pancreatic tumorigenesisMin-Wei Yang, Qin-Yuan Jia, Da-Peng Xu, et al.
Molecular Cancer|November 8, 2011
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumorsXi Xia, Teng Ji, Pingbo Chen, et al.
Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Nature Communications|May 2, 2018
C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylationDan Liu, Xiao-Xue Zhang, Meng-Chen Li, et al.
Cell Reports|March 2, 2022
Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancerTian-Qi Gong, Yi-Zhou Jiang, Chen Shao, et al.
Clinical Chemistry and Laboratory Medicine|September 7, 2023
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomicsFenfen Wang, Xinxing Li, Mengxing Li, et al.
Signal Transduction and Targeted Therapy|September 12, 2022
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivationGuan-Nan Li, Xue-Jiao Zhao, Zhen Wang, et al.
Nature Genetics|September 28, 2023
Molecular classification of hormone receptor-positive HER2-negative breast cancerXi Jin, Yi-Fan Zhou, Ding Ma, et al.
Pageof 92